Research IPOs and Discover New Stocks
Ascentage Pharma, a clinical-stage Chinese biotech developing novel therapies for cancer, hepatitis B, and age-related diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Ascentage's lead drug olverembatinib, a...read more
Helio Corporation, which designs, assembles, and tests space flight equipment, filed on Friday with the SEC to raise up to $15 million in an NYSE American uplisting. It is currently listed on the OTC Pink under the symbol HLEO The Berkeley, CA-based company...read more
Park Ha Biological Technology, which sells skincare and cosmetic products in China, raised $4.8 million by offering 1.2 million shares at $4, the low end of the range of $4 to $6. ...read more
IPO PRO
TIP
Researching by industry will help you uncover new investment ideas based on new and emerging technologies and industries. Click on an industry to learn more about IPOs launching soon, then use IPO Pro to further research historical performance and upcoming IPOs.
TRY IPO PRO| Ticker | Company | Ticker | Shares (M) | Price Range | Deal Size ($M) | Underwriters | |
|---|---|---|---|---|---|---|---|
| FTRK | Fast Track Group | FTRK | 00/00/00 | 3.0 | $4.00 - $5.00 | $14 | Network 1 |
IPO PRO TIP
Create custom screens and filters to see when IPOs are coming up. Explore full IPO Calendar
| Ticker | Company | Ticker | Offer Date | Deal Size ($M) | Current Price | Today's Change | Return from IPO |
|---|---|---|---|---|---|---|---|
| HIT | Health In Tech | HIT | 12/20/24 | $9 | $5.46 |
$0.00
(0.0%)
|
36.5% |
| YAAS | Youxin Technology | YAAS | 12/19/24 | $10 | $3.30 |
$0.00
(0.0%)
|
-26.7% |
| LSE | Leishen Energy | LSE | 12/18/24 | $6 | $4.76 |
$0.00
(0.0%)
|
19.0% |
IPO PRO TIP
The IPO price is the price the underwriters will sell stock to institutional and accredited investors. Learn more at IPO University
Get the Investment Case
Enhance your knowledge with IPO Pro. Screen for new stocks and find opportunities that others miss.
Start your 7-day trial of IPO Pro
